| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |